La Jolla Institute for Immunology
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$62,503,266
Receivables (Non-Related)
26%
Investments
24%
Property, Plant, & Equipment (net)
20%
Cash & Equivalents
14%
Other Assets
14%
Prepaid Expenses
2%
Related-Party Receivables
<1%
Inventories
0%
Liabilities in 2024 (Year End)
$34,989,684
Payables & Accruals
62%
Other Liabilities
17%
Notes Payable / Debt (Non-Related)
14%
Deferred Revenue
7%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$8,977,574
$9,027,020
+1%
Receivables (Non-Related)
$11,787,639
$16,126,878
+37%
Related-Party Receivables
$183,077
$148,078
-19%
Inventories
-
-
-
Prepaid Expenses
$714,353
$958,516
+34%
Investments
$18,248,564
$14,928,850
-18%
Property, Plant, & Equipment (net)
$15,759,604
$12,796,012
-19%
Other Assets
$9,671,611
$8,517,912
-12%
Total Assets
$65,342,422
$62,503,266
-4%
Liabilities
2023
2024
Change
Payables & Accruals
$18,411,282
$21,674,037
+18%
Grants Payable
-
-
-
Deferred Revenue
$644,681
$2,492,372
+287%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$5,956,249
$4,985,085
-16%
Related-Party Payables
-
-
-
Other Liabilities
$10,783,315
$5,838,190
-46%
Total Liabilities
$35,795,527
$34,989,684
-2%
Net assets
2023
2024
Change
Restricted Net Assets
$12,830,801
$15,143,046
+18%
Unrestricted Net Assets
$16,716,094
$12,370,536
-26%
Net assets
2023
2024
Change
Net assets
+$29,546,895
+$27,513,582
-7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)